Metformin formulations and delivery methods
Pro Research Analysisby 
Searched over 200M research papers
Metformin Formulations: Oral, Transdermal, and Advanced Delivery Systems
Oral Metformin Formulations and Their Limitations
Metformin is most commonly administered orally due to its convenience and cost-effectiveness. However, oral metformin has notable limitations, including low bioavailability (about 50–60%) and gastrointestinal side effects, which can limit its use and effectiveness in some patients 610. To address these issues, researchers have developed sustained-release oral formulations, such as in-situ floating gels using biopolymers like sodium alginate and pectin. These gels can float in the stomach and gradually release metformin over 8 hours, improving absorption and providing sustained drug levels .
Liposomal and Nanoparticulate Metformin Delivery
Liposomal formulations encapsulate metformin in small vesicles, which can enhance drug stability, control release, and potentially improve bioavailability. Studies have shown that liposomal metformin can be prepared using various methods (e.g., physical dispersion, ether injection, thin film hydration), with differences in drug entrapment efficiency, stability, and release profiles. These formulations have demonstrated sustained drug release and efficient skin permeation, suggesting potential for both oral and topical delivery 138. Nanoparticulate and microparticulate systems, including microspheres and nanoparticles, have also been developed to control drug release, reduce dosing frequency, and minimize side effects 26.
Transdermal Metformin Delivery Systems
Transdermal drug delivery systems (TDDS) offer an alternative to oral administration, aiming to bypass gastrointestinal side effects and improve patient compliance. Matrix-type patches using polymers like hydroxypropyl methylcellulose and ethyl cellulose, often with permeation enhancers such as eucalyptus oil, have been shown to provide sustained and homogeneous drug release over 24 hours . Bilosomes, which are nano-vesicles containing bile salts, have also been explored as transdermal carriers. These systems significantly enhance metformin permeation through the skin and offer improved entrapment efficiency and stability compared to non-formulated drug .
Microneedle and Glucose-Responsive Delivery Technologies
Innovative delivery methods such as dissolving microneedles loaded with glucose-responsive microparticles have been developed to provide selective, controlled metformin release in response to blood glucose levels. These systems deliver metformin through the skin, avoiding gastrointestinal side effects and offering rapid and sustained glucose reduction in animal models. The microneedle approach is non-toxic, maintains skin integrity, and shows promise for more effective and patient-friendly diabetes management 410.
Future Directions and Considerations
Recent advances in metformin delivery systems—including fast-dissolving tablets, hydrogels, micro/nanoparticles, and microneedles—are aimed at improving drug targeting, bioavailability, and patient adherence. These technologies also open possibilities for expanding metformin’s therapeutic uses beyond diabetes, such as in cancer treatment. However, challenges remain in terms of formulation complexity, cost, biocompatibility, stability, and regulatory approval 610.
Conclusion
A wide range of metformin formulations and delivery methods are being developed to overcome the limitations of traditional oral therapy. These include sustained-release oral gels, liposomal and nanoparticulate systems, transdermal patches and bilosomes, and advanced microneedle technologies. These innovations aim to improve metformin’s bioavailability, reduce side effects, and enhance patient compliance, offering promising alternatives for diabetes management and beyond 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic